Insight_03 // The Business and Economic Case for Vaccine Equity

Global herd immunity is being hailed as a key factor to opening up our economies and societies to kickstart the Covid-19 recovery. But this will depend on mass immunisation and equitable distribution of vaccines between rich and poor countries. In this edition, we make the business and economic case for vaccine equity. Download the March/April […]

Global herd immunity is being hailed as a key factor to opening up our economies and societies to kickstart the Covid-19 recovery. But this will depend on mass immunisation and equitable distribution of vaccines between rich and poor countries. In this edition, we make the business and economic case for vaccine equity.

Download the March/April edition of our Insights series here.